HIM
MRNA icon

Hillsdale Investment Management’s Moderna MRNA Stock Holding History

Hillsdale Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40
Closed -$5K – 595
2022
Q3 		$5K Sell
40
-2,100
-98% -$319K ﹤0.01% 529
2022
Q2 		$306K Sell
2,140
-30
-1% -$4.29K 0.02% 390
2022
Q1 		$374K Buy
2,170
+100
+5% +$16.8K 0.02% 389
2021
Q4 		$525K Sell
2,070
-332
-14% -$97.1K 0.04% 376
2021
Q3 		$924K Sell
2,402
-848
-26% -$313K 0.07% 266
2021
Q2 		$763K Buy
+3,250
New +$581K 0.06% 294

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hillsdale Investment Management's MRNA Position: Q4 2022 in Review

Hillsdale Investment Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 40 shares — an estimated $5K sold.

Hillsdale Investment Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $924K in Q3 2021. 1,072 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Hillsdale Investment Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 40 Moderna shares in Q4 2022, an estimated $5K.
  • Hillsdale Investment Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Hillsdale Investment Management's Moderna position peaked at $924K in Q3 2021.
  • 1,072 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Hillsdale Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.